SCHEMBL23770819

SCHEMBL23770819

Fc1cccc(-c2nc(NSc3cccc(N4CCNCC4)n3)ccc2Cl)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 3/20 0.41
HTR3E A5X5Y0 2/20 0.41
HTR3B O95264 2/20 0.41
HTR3D Q70Z44 2/20 0.41
HTR3C Q8WXA8 2/20 0.41
ALDH1A1 P00352 1/20 0.41
PTPN11 Q06124 2/20 0.41
SCN9A Q15858 1/20 0.37
HTR1A P08908 2/20 0.34
HTR7 P34969 2/20 0.34
BPTF Q12830 1/20 0.34
HTR2B P41595 1/20 0.34
HTR6 P50406 1/20 0.34
ADRB2 P07550 1/20 0.33
MAPK14 Q16539 1/20 0.33
SLC6A2 P23975 1/20 0.32
ADRB1 P08588 2/20 0.32
DRD2 P14416 1/20 0.32
DRD3 P35462 1/20 0.32
ALK Q9UM73 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770650 0.91 PTPN11 (0.32) PTPN11
SCHEMBL23770731 0.91 HTR3A (0.40) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL23770606 0.89 ADRB2 (0.43) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL23770669 0.86 HTR3A (0.40) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL23770862 0.85 HTR3E (0.42) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL23770808 0.83 HTR3E (0.38) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL23770499 0.82 PTPN11 (0.36) PTPN11
SCHEMBL23770450 0.81 HTR3E (0.43) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL23770739 0.80 CNR2 (0.38) PTPN11ADRB2
SCHEMBL19968829 0.79 PTPN11 (0.40) HTR3AHTR3EHTR3BHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed